Similar articles

• Effects of chronic treatment with amino-oxyacetic acid or sodium n-dipropylacetate on brain GABA levels and the development and regression of cobalt epileptic foci in rats.

  Emson PC. Emson PC. J Neurochem. 1976 Dec;27(6):1489-94. doi: 10.1111/j.1471-4159.1976.tb02634.x. J Neurochem. 1976. PMID: 794443 No abstract available.
• Kinetics of in vivo conversion of gamma-[3H]aminobutyric acid to gamma-[3H]hydroxybutyric acid by rat brain.

  Gold BI, Roth RH. Gold BI, et al. J Neurochem. 1977 May;28(5):1069-73. doi: 10.1111/j.1471-4159.1977.tb10670.x. J Neurochem. 1977. PMID: 864458 No abstract available.
• The use of inhibitors of GABA-transaminase for the determination of GABA turnover in mouse brain regions: an evaluation of aminooxyacetic acid and gabaculine.

  Bernasconi R, Maitre L, Martin P, Raschdorf F. Bernasconi R, et al. J Neurochem. 1982 Jan;38(1):57-66. doi: 10.1111/j.1471-4159.1982.tb10853.x. J Neurochem. 1982. PMID: 7108535 No abstract available.
• Anticonvulsant activity of aminooxyacetic acid on convulsions induced by thiosemicarbazide.

  Murakami Y, Abe M, Murakami K. Murakami Y, et al. J Neurochem. 1976 Mar;26(3):655-6. doi: 10.1111/j.1471-4159.1976.tb01532.x. J Neurochem. 1976. PMID: 1262886 No abstract available.
• Epilepsy and gamma-aminobutyric acid-mediated inhibition.

  Meldrum BS. Meldrum BS. Int Rev Neurobiol. 1975;17:1-36. doi: 10.1016/s0074-7742(08)60205-6. Int Rev Neurobiol. 1975. PMID: 166954 Review. No abstract available.